OBJECTIVE To review existing literature on depression during pregnancy and to provide
information for family physicians in order to promote early detection and treatment. QUALITY …

CNS-active drugs are used relatively often during pregnancy. Use during early pregnancy
may increase the risk of a congenital malformation; use during the later part of pregnancy …

BackgroundConcerns have been expressed about possible adverse effects of the use of
antidepressant medication during pregnancy, including risk for neonatal pathology and the …

This thoroughly revised and updated reference addresses the drugs and chemicals causing
malformations and congenital anomalies in the human fetus-comprehensively reviewing …

Objective To compare the prevalence and clinical characteristics of neonatal abstinence
syndrome in neonates exposed and not exposed to selective serotonin reuptake inhibitors …

Julia Flint1, Sonia Panchal2, Alice Hurrell3, Maud van de Venne4, Mary Gayed5, Karen
Schreiber6, 7, Subha Arthanari8, Joel Cunningham3, Lucy Flanders3, Louise Moore9, Amy …

Background Exposure to antidepressants during the third trimester of pregnancy has been
associated with an increased risk for adverse birth outcomes, including preterm birth …

Objectives: To investigate delivery outcome after the use of antidepressants in early
pregnancy. Methods: Using an ongoing prospective recording of drug use in early …

Depression during pregnancy is common, affecting an estimated 20% of women. However,
conflicting data exist concerning the outcomes of this disorder. Thus, we reviewed studies …

Background A substantial number of women of childbearing age suffer from depression.
Despite this, relatively little is known about the safety of antidepressant use during …